Literature DB >> 15681853

Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid.

Jorge Albores-Saavedra1, Kelley Carrick.   

Abstract

A critical review of the literature reveals that different types of thyroid carcinomas have been interpreted as poorly differentiated, including the tall and columnar cell variants as well as carcinomas with insular, trabecular, and solid growth patterns. In some publications the growth patterns have been emphasized, while in others histologic patterns and cytologic features are considered important for identification. However, insular, trabecular, nodular, and solid growth patterns lack specificity because they can be observed in hyperplastic lesions and benign thyroid tumors. The cytologic features of the vast majority of poorly differentiated thyroid carcinomas are similar to or overlap with those of papillary or follicular carcinomas. Cytologic atypia, mitotic activity, and necrosis--believed by some investigators to be useful clues in the diagnosis of poorly differentiated carcinomas--do not reflect cell differentiation, especially in endocrine organs. It is therefore not surprising that the immunohistochemical profile and the molecular abnormalities described in this heterogeneous group of carcinomas lack specificity and are not useful diagnostic tools. Because poorly differentiated thyroid carcinomas have not been well defined, currently it is not possible to set the threshold between well-differentiated and poorly differentiated thyroid carcinomas with follicular phenotype. The authors believe that the vast majority of poorly differentiated thyroid carcinomas are in fact examples of papillary or follicular carcinomas with unusual growth patterns.

Entities:  

Mesh:

Year:  2004        PMID: 15681853     DOI: 10.1385/ep:15:4:297

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  34 in total

1.  Poorly differentiated thyroid carcinoma--it is important.

Authors:  L A Akslen; V A LiVolsi
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

2.  Macrofollicular variant of papillary thyroid carcinoma with minor insular component.

Authors:  J Albores-Saavedra; I Housini; F Vuitch; W H Snyder
Journal:  Cancer       Date:  1997-09-15       Impact factor: 6.860

3.  Thyroid cancer in patients with familial adenomatous polyposis.

Authors:  N D Perrier; J A van Heerden; J R Goellner; E D Williams; H Gharib; P Marchesa; J M Church; V W Fazio; D R Larson
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

4.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

5.  Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid.

Authors:  M Sobrinho-Simões; J M Nesland; J V Johannessen
Journal:  Am J Clin Pathol       Date:  1988-02       Impact factor: 2.493

6.  p53 gene mutations in radiation-induced thyroid cancer.

Authors:  L Fogelfeld; T K Bauer; A B Schneider; J E Swartz; R Zitman
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

7.  RET activation and clinicopathologic features in poorly differentiated thyroid tumors.

Authors:  Massimo Santoro; Mauro Papotti; Gennaro Chiappetta; Ginesa Garcia-Rostan; Marco Volante; Chaline Johnson; Robert L Camp; Francesca Pentimalli; Carmen Monaco; Agustin Herrero; Maria Luisa Carcangiu; Alfredo Fusco; Giovanni Tallini
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

Review 8.  Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm.

Authors:  H R Harach; G T Williams; E D Williams
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

9.  Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma.

Authors:  H L Evans
Journal:  Am J Clin Pathol       Date:  1986-01       Impact factor: 2.493

10.  Prognostic factors in follicular carcinoma of the thyroid.

Authors:  M Jorda; R Gonzalez-Campora; J Mora; A Herrero-Zapatero; C Otal; H Galera
Journal:  Arch Pathol Lab Med       Date:  1993-06       Impact factor: 5.534

View more
  7 in total

Review 1.  Update in thyroid fine needle aspiration.

Authors:  William C Faquin; Massimo Bongiovanni; Peter M Sadow
Journal:  Endocr Pathol       Date:  2011-12       Impact factor: 3.943

Review 2.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

3.  Nodal metastasis in well-differentiated follicular carcinoma of the thyroid: Its incidence and clinical significance.

Authors:  Mitsuyoshi Hirokawa; Yasuhiro Ito; Seiji Kuma; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Akira Miyauchi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

4.  Postoperative ultrasonography surveillance in patients with follicular thyroid carcinoma: a multicenter study.

Authors:  Hye Jin Baek; Dong Wook Kim; Song Lee; Inseon Ryoo; Chang Yoon Lee; Yoon Jung Choi; Jin Yong Sung
Journal:  Radiol Med       Date:  2017-03-14       Impact factor: 3.469

Review 5.  The many faces and mimics of papillary thyroid carcinoma.

Authors:  Jorge Albores-Saavedra; Jianhua Wu
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

6.  Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature.

Authors:  Rogelio Gonzalez-Gonzalez; Ronell Bologna-Molina; Ramón Gil Carreon-Burciaga; Marcelo Gómezpalacio-Gastelum; Nelly Molina-Frechero; Sirced Salazar-Rodríguez
Journal:  ISRN Oncol       Date:  2011-12-06

7.  Poorly differentiated thyroid carcinoma with rhabdoid phenotype: a diagnostic dilemma--report of a rare case.

Authors:  S Agarwal; M C Sharma; M Aron; C Sarkar; N Agarwal; S Chumber
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.